Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China flag China · Delayed Price · Currency is CNY
47.54
+0.10 (0.21%)
At close: Feb 6, 2026

SHE:300957 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,5741,8102,0912,5142,035751.95
Short-Term Investments
--310480.121,530-
Trading Asset Securities
2,3672,4281,2381,434781.15-
Cash & Short-Term Investments
3,9414,2393,6404,4284,346751.95
Cash Growth
25.39%16.45%-17.80%1.89%477.93%42.62%
Accounts Receivable
738.071,047742.92508.76328.3326.48
Other Receivables
41.67173.14157.8720.4737.8119.33
Receivables
779.741,220900.79529.23366.11345.81
Inventory
775.78611.89904.41670.75463.27253.75
Prepaid Expenses
-6.956.98-2.925.25
Other Current Assets
220.855.3170.5787.0146.9534.41
Total Current Assets
5,7176,1335,5235,7155,2251,391
Property, Plant & Equipment
860.13936.82808.14665.36431.96109.29
Long-Term Investments
442.33375.95298.4682.78--
Goodwill
323.05323.05413.74---
Other Intangible Assets
559.41258.52193.1177.9464.5955.16
Long-Term Deferred Tax Assets
144.42129.3493.1352.1215.5813.35
Long-Term Deferred Charges
113.86113.5993.3266.7341.0220.36
Other Long-Term Assets
41.4733.3884.4559.6334.3112.53
Total Assets
8,2028,3047,5076,7205,8121,602
Accounts Payable
566.91447.18401.93372.37361.61134.84
Accrued Expenses
100.45457.76469.93312.06285.73150.21
Short-Term Debt
453.13314.56103.82---
Current Portion of Leases
72.3563.3342.162.4248.91-
Current Income Taxes Payable
96.1170105.22109.6997.5465.78
Current Unearned Revenue
81.5198.9750.0558.1271.1936.5
Other Current Liabilities
200.8166.13118.1677.2134.783.86
Total Current Liabilities
1,5711,5181,291991.87899.75391.19
Long-Term Debt
207.96321.664.7---
Long-Term Leases
81.58118.2363.2850.9576.29-
Long-Term Unearned Revenue
90.43112.3782.8655.576.37.41
Long-Term Deferred Tax Liabilities
22.0933.340.458.361.69-
Other Long-Term Liabilities
7.4112.258.610.5501.45
Total Liabilities
1,9812,1161,4911,1171,034400.05
Common Stock
423.6423.6423.6423.6423.6360
Additional Paid-In Capital
2,8282,8172,8462,8462,84625.71
Retained Earnings
2,9712,9522,7012,2831,486813.3
Treasury Stock
-144.96-144.96-109.84---
Comprehensive Income & Other
1.722.050.05-00-
Total Common Equity
6,0806,0505,8615,5534,7551,199
Minority Interest
141.24137.92154.8249.4823.262.81
Shareholders' Equity
6,2216,1886,0165,6024,7781,202
Total Liabilities & Equity
8,2028,3047,5076,7205,8121,602
Total Debt
815.02817.77213.9113.36125.2-
Net Cash (Debt)
3,1263,4213,4264,3154,221751.95
Net Cash Growth
30.74%-0.14%-20.60%2.23%461.28%46.79%
Net Cash Per Share
7.388.168.1010.1810.372.09
Filing Date Shares Outstanding
419.95421.29420.61423.6423.6423.6
Total Common Shares Outstanding
419.95421.29420.61423.6423.6360
Working Capital
4,1464,6154,2314,7234,325999.98
Book Value Per Share
14.4814.3613.9313.1111.233.33
Tangible Book Value
5,1975,4685,2545,4754,6911,144
Tangible Book Value Per Share
12.3812.9812.4912.9211.073.18
Buildings
-251.48261.250.3533.833.8
Machinery
-649.81527.8228.01124.768.73
Construction In Progress
-50.7640.22349.47197.2940.75
Source: S&P Global Market Intelligence. Standard template. Financial Sources.